Insider Trades
News
prnewswire.comCROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTIONprnewswire.comJun 18
gurufocus.comFDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lunggurufocus.comMay 29
gurufocus.comIMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancergurufocus.comMay 28
prnewswire.comCROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTIONprnewswire.comMay 18
247wallst.comThe Iran War Sent Oil Above $100. These 3 Royalty Trusts Are Quietly Paying Double Digit Yields Because of It247wallst.comMay 14